|
1
|
Kaye FJ: Mutation-associated fusion cancer
genes in solid tumors. Mol Cancer Ther. 8:1399–1408. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Prensner JR and Chinnaiyan AM: Oncogenic
gene fusions in epithelial carcinomas. Curr Opin Genet Dev.
19:82–91. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Edwards PA: Fusion genes and chromosome
translocations in the common epithelial cancers. J Pathol.
220:244–254. 2010.PubMed/NCBI
|
|
4
|
Licht JD: Acute promyelocytic leukemia -
weapons of mass differentiation. N Engl J Med. 360:928–930. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Nambiar M, Kari V and Raghavan SC:
Chromosomal translocations in cancer. Biochim Biophys Acta.
1786:139–152. 2008.PubMed/NCBI
|
|
6
|
Heim S and Mitelman F: Molecular screening
for new fusion genes in cancer. Nat Genet. 40:685–686. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Howarth KD, Blood KA, Ng BL, Beavis JC,
Chua Y, Cooke SL, Raby S, Ichimura K, Collins VP, Carter NP, et al:
Array painting reveals a high frequency of balanced translocations
in breast cancer cell lines that break in cancer-relevant genes.
Oncogene. 27:3345–3359. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Maher CA, Kumar-Sinha C, Cao X,
Kalyana-Sundaram S, Han B, Jing X, Sam L, Barrette T, Palanisamy N
and Chinnaiyan AM: Transcriptome sequencing to detect gene fusions
in cancer. Nature. 458:97–101. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chen CF, Hsu EC, Lin KT, Tu PH, Chang HW,
Lin CH, Chen YJ, Gu DL, Lin CH, Wu JY, et al: Overlapping
high-resolution copy number alterations in cancer genomes
identified putative cancer genes in hepatocellular carcinoma.
Hepatology. 52:1690–1701. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang F, Denison S, Lai JP, Philips LA,
Montoya D, Kock N, Schüle B, Klein C, Shridhar V, Roberts LR, et
al: Parkin gene alterations in hepatocellular carcinoma. Genes
Chromosomes Cancer. 40:85–96. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Adélaïde J, Huang HE, Murati A, Alsop AE,
Orsetti B, Mozziconacci MJ, Popovici C, Ginestier C, Letessier A,
Basset C, et al: A recurrent chromosome translocation breakpoint in
breast and pancreatic cancer cell lines targets the
neuregulin/NRG1 gene. Genes Chromosomes Cancer. 37:333–345.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Huang HE, Chin SF, Ginestier C, Bardou VJ,
Adélaïde J, Iyer NG, Garcia MJ, Pole JC, Callagy GM, Hewitt SM, et
al: A recurrent chromosome breakpoint in breast cancer at the
NRG1/neuregulin 1/heregulin gene. Cancer Res. 64:6840–6844.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Prentice LM, Shadeo A, Lestou VS, Miller
MA, deLeeuw RJ, Makretsov N, Turbin D, Brown LA, Macpherson N,
Yorida E, et al: NRG1 gene rearrangements in clinical breast
cancer: Identification of an adjacent novel amplicon associated
with poor prognosis. Oncogene. 24:7281–7289. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Fernandez-Banet J, Lee NP, Chan KT, Gao H,
Liu X, Sung WK, Tan W, Fan ST, Poon RT, Li S, et al: Decoding
complex patterns of genomic rearrangement in hepatocellular
carcinoma. Genomics. 103:189–203. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tominaga K, Kondo C, Johmura Y, Nishizuka
M and Imagawa M: The novel gene fad104, containing a
fibronectin type III domain, has a significant role in
adipogenesis. FEBS Lett. 577:49–54. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kishimoto K, Kato A, Osada S, Nishizuka M
and Imagawa M: Fad104, a positive regulator of adipogenesis,
negatively regulates osteoblast differentiation. Biochem Biophys
Res Commun. 397:187–191. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lin F, Ren XD, Pan Z, Macri L, Zong WX,
Tonnesen MG, Rafailovich M, Bar-Sagi D and Clark RA: Fibronectin
growth factor-binding domains are required for fibroblast survival.
J Invest Dermatol. 131:84–98. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Obara M, Sakuma T and Fujikawa K: The
third type III module of human fibronectin mediates cell adhesion
and migration. J Biochem. 147:327–335. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cai C, Rajaram M, Zhou X, Liu Q, Marchica
J, Li J and Powers RS: Activation of multiple cancer pathways and
tumor maintenance function of the 3q amplified oncogene
FNDC3B. Cell Cycle. 11:1773–1781. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yang J and Weinberg RA:
Epithelial-mesenchymal transition: At the crossroads of development
and tumor metastasis. Dev Cell. 14:818–829. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Pinzani M: Epithelial-mesenchymal
transition in chronic liver disease: Fibrogenesis or escape from
death? J Hepatol. 55:459–465. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Steinberg SF: Structural basis of protein
kinase C isoform function. Physiol Rev. 88:1341–1378. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Win HY and Acevedo-Duncan M: Role of
protein kinase C-iota in transformed non-malignant RWPE-1 cells and
androgen-independent prostate carcinoma DU-145 cells. Cell Prolif.
42:182–194. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Takagawa R, Akimoto K, Ichikawa Y, Akiyama
H, Kojima Y, Ishiguro H, Inayama Y, Aoki I, Kunisaki C, Endo I, et
al: High expression of atypical protein kinase C lambda/iota in
gastric cancer as a prognostic factor for recurrence. Ann Surg
Oncol. 17:81–88. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kikuchi K, Soundararajan A, Zarzabal LA,
Weems CR, Nelon LD, Hampton ST, Michalek JE, Rubin BP, Fields AP
and Keller C: Protein kinase C iota as a therapeutic target in
alveolar rhabdomyosarcoma. Oncogene. 32:286–295. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Justilien V, Walsh MP, Ali SA, Thompson
EA, Murray NR and Fields AP: The PRKCI and SOX2
oncogenes are coamplified and cooperate to activate Hedgehog
signaling in lung squamous cell carcinoma. Cancer Cell. 25:139–151.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Haverty PM, Hon LS, Kaminker JS, Chant J
and Zhang Z: High-resolution analysis of copy number alterations
and associated expression changes in ovarian tumors. BMC Med
Genomics. 2:212009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Du GS, Wang JM, Lu JX, Li Q, Ma CQ, Du JT
and Zou SQ: Expression of P-aPKC-iota, E-cadherin, and beta-catenin
related to invasion and metastasis in hepatocellular carcinoma. Ann
Surg Oncol. 16:1578–1586. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Fields AP and Regala RP: Protein kinase C
iota: Ηuman oncogene, prognostic marker and therapeutic target.
Pharmacol Res. 55:487–497. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Murray NR, Kalari KR and Fields AP:
Protein kinase Cι expression and oncogenic signaling mechanisms in
cancer. J Cell Physiol. 226:879–887. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Win HY and Acevedo-Duncan M: Atypical
protein kinase C phosphorylates IKKalphabeta in transformed
non-malignant and malignant prostate cell survival. Cancer Lett.
270:302–311. 2008. View Article : Google Scholar : PubMed/NCBI
|
